Primary Site >> Liver Cancer
Gene >> SERPINB3
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
|
Ref: [Studies on antigen associated with human squamous cell carcinoma (SCC antigen) in patients with esophageal carcinoma]. PMID: 2747608 |
Ref: Squamous cell carcinoma antigen-1 (SERPINB3) polymorphism in chronic liver disease. PMID: 18657489 |
Ref: Over-expression of SERPINB3 in hepatoblastoma: a possible insight into the genesis of this tumour? PMID: 21737255 Ref: IgM-linked SerpinB3 and SerpinB4 in sera of patients with chronic liver disease. PMID: 22808225 |
Ref: MicroRNAs and SerpinB3 in hepatocellular carcinoma. PMID: 24496037 Ref: Hepatic progenitor cells express SerpinB3. PMID: 24517394 Ref: SERPINB3 is associated with TGF-beta1 and cytoplasmic beta-catenin expression in hepatocellular carcinomas with poor prognosis. PMID: 24809782 Ref: SERPINB3 protects from oxidative damage by chemotherapeutics through inhibition of mitochondrial respiratory complex I. PMID: 24810714 Ref: Squamous cell carcinoma antigen 1 and 2 mRNA and anew variant expressed in hepatocellular carcinoma. PMID: 25150316 Ref: Role of SERPINB3 in hepatocellular carcinoma. PMID: 25332258 |
Ref: Hypoxia up-regulates SERPINB3 through HIF-2alpha in human liver cancer cells. PMID: 25544768 Ref: Overexpression of squamous cell carcinoma antigen 1 is associated with the onset and progression of human hepatocellular carcinoma. PMID: 25819271 Ref: SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity. PMID: 26634820 |
Ref: Prediction of HBF-0259 interactions with hepatitis B Virus receptors and surface antigen secretory factors. PMID: 28466034 |
Ref: Binding and Uptake into Human Hepatocellular Carcinoma Cells of Peptide-Functionalized Gold Nanoparticles. PMID: 27771945 Ref: Re-programming pullulan for targeting and controlled release of doxorubicin to the hepatocellular carcinoma cells. PMID: 28192167 Ref: SerpinB3 Promotes Pro-fibrogenic Responses in Activated Hepatic Stellate Cells. PMID: 28611447 |
Ref: SerpinB3 induces dipeptidyl-peptidase IV/CD26 expression and its metabolic effects in hepatocellular carcinoma. PMID: 29524519 |